Tidal Investments LLC Increases Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Tidal Investments LLC raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 348.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 99,123 shares of the company’s stock after purchasing an additional 77,005 shares during the quarter. Tidal Investments LLC’s holdings in HCA Healthcare were worth $29,752,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Sanders Capital LLC grew its stake in HCA Healthcare by 1.0% during the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock valued at $3,498,417,000 after purchasing an additional 116,826 shares during the last quarter. First Eagle Investment Management LLC boosted its stake in shares of HCA Healthcare by 0.5% in the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock worth $1,351,830,000 after buying an additional 23,177 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of HCA Healthcare by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock worth $1,159,882,000 after buying an additional 50,321 shares during the last quarter. Capital World Investors boosted its stake in shares of HCA Healthcare by 0.7% in the fourth quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock worth $878,975,000 after buying an additional 19,121 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of HCA Healthcare in the fourth quarter worth about $840,286,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, COO Jon M. Foster sold 15,698 shares of the firm’s stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer now directly owns 12,646 shares in the company, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on HCA shares. Royal Bank of Canada lowered their target price on HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating on the stock in a research note on Monday, April 28th. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. StockNews.com upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, April 28th. Robert W. Baird reiterated a “neutral” rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Finally, Bank of America lowered their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $381.13.

HCA Healthcare Price Performance

NYSE:HCA opened at $387.49 on Friday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market cap of $93.22 billion, a PE ratio of 17.64, a P/E/G ratio of 1.10 and a beta of 1.46. The stock has a 50 day moving average price of $340.72 and a 200 day moving average price of $328.51.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm had revenue of $18.32 billion during the quarter, compared to analysts’ expectations of $18.26 billion. During the same quarter last year, the firm earned $5.36 earnings per share. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.74%. HCA Healthcare’s dividend payout ratio (DPR) is 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.